Disclaimer: This article was published in 2021 and reflects the information available at that time.
  There are certain medications that appear in notifications to PDL frequently. While some of these medications are considered low risk and have less potential for harm, it is important for pharmacists to remain vigilant when checking all prescriptions. Here are some examples of medications that have recently seen an increase in reports to PDL. Ozempic injections Ozempic™ is a non-insulin injectable used to treat Type 2 diabetes in adults 18 years and above. Since semaglutide induces side effects on initiation, lower doses are required for at least the first four weeks of use….

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Related Practice Alerts

Is this the right jab? RSV vaccine selection reminder
25 August 2026
NationalDispensingProfessional activitiesVaccinationRegulatory and compliancePractice support, tips and tools
Learn more
Unauthorised filming in pharmacies – managing risks to staff, privacy and professional practice
4 August 2026
NationalMental healthLeadership and communicationIncident managementRegulatory and compliancePharmacist wellbeingPractice support, tips and toolsPrivacy and consent
Learn more
Pause before you dispense – fraud, forgery and misrepresentation
25 June 2026
NationalDispensingProfessional activitiesRegulatory and compliancePractice support, tips and tools
Learn more